Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2NIH 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 4Other solid neoplasm 2Gynecologic 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Cisplatin 28Irinotecan 18Gemcitabine 18Paclitaxel 14alvocidib 13Fluorouracil 11Oxaliplatin 10Cyclophosphamide 10Carboplatin 10Leucovorin 8Bortezomib 8Biopsy 8Taxes 7Radiotherapy 7Pemetrexed 7Magnetic Resonance Spectroscopy 7Doxorubicin 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Specimen Handling 6tanespimycin 5Vorinostat 5LMB-100 5Early Intervention, Educational 5Bevacizumab 5temsirolimus 4sargramostim 4Sorafenib 4Sirolimus 4Platinum 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × eribulin × Other solid neoplasm × Clear all
NCT00415324 2014-05-20

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00047034 2013-01-07

E7389 in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
31 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡